Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid

Infectious Diseases in Obstetrics and Gynecology

Volumn 9, Issue 4, 2001, Pages 245-247

  Silverman, Neil S ^a   Morgan, Margie ^a   Nichols, W S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Boric Acid; Candida; Vaginitis; Vulvovaginitis

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BORIC ACID; CLINDAMYCIN; FLUCONAZOLE; KETOCONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA LUSITANIAE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; SUPPOSITORY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VAGINA CANDIDIASIS; VULVOVAGINITIS;

EID: 0035705693     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1155/S1064744901000400     Document Type: Article

References (12)

1. Vulvovaginits. When Candida becomes a problem
2. Epidemiology of vaginal Candida infection: Significance of numbers of vaginal yeasts and their biotypes
3. Evolving pathogens in vulvovaginal candidiasis: Implications for patient care
4. Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata
5. Candidiasis: Speciation and therapy
6. Fungemia in the immunocompromised host: Changing patterns, antigenemia, high mortality
7. Development of resistance to amphotericin B in Candida lusitaniae infecting a human
8. Candida lusitaniae: A cause of breakthrough fungemia in cancer patients
9. Emergence of a new opportunistic pathogen, Candida lusitaniae
10. Recurrent vulvovaginal candidiasis: A prospective study of the efficacy of maintenance ketoconazole therapy
11. Boric acid treatment of vulvovaginal candidiasis
12. Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy